Milestone Scientific Stock Performance
| MLSS Stock | USD 0.29 -0.01 -3.33% |
The firm maintains a market beta of 0.0527, which implies relatively modest fluctuations relative to the market. Returns on Milestone Scientific tend to trail the broader market in strong rallies but hold up better when sentiment turns negative. At this point, Milestone Scientific has a negative expected return of -0.24%. Please make sure to verify Milestone Scientific's relationship between the Skewness and day typical price, to decide if Milestone Scientific's performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weak
Weak | Strong |
Over the last 90 days, Milestone Scientific generated negative risk-adjusted returns and added little value for investors with long positions. The result matters because weak risk-adjusted return can persist even when isolated price moves briefly look constructive. In spite of uncertain performance in the last few months, the stock's basic indicators remain comparatively stable, which may send shares a bit higher in April 2026. The newest uproar may also be a sign of mid-term up-swing for the firm's private investors. Learn More
Last Split Factor 1:3 | Last Split Date 2004-01-14 |
1 | Genesis Security Reduces False Alarms by 62 percent with Milestone and Actuate AI Integration | 01/13/2026 |
2 | Keenova Marks 100K Peyronies Disease Patients--a Major Milestone for an Often-Stigmatized Mens Health Condition | 01/21/2026 |
3 | DPC Dash-Dominos Pizza China Hits Symbolic Milestone 1,405th Store Opens in Sanya, Matching Its HKEX Stock Ticker | 01/26/2026 |
4 | happyactually Announces Dr. Maren Voss as Chief Happiness Officer and Scientific Advisor | 01/27/2026 |
5 | Hadrian Celebrates Ribbon Cutting of Factory 3 in Mesa, Arizona, Marking Major Milestone in AI-Powered Manufacturing Expansion | 01/29/2026 |
6 | Milestone Scientific Launches CompuFlo Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions Plans National... | 02/23/2026 |
7 | REGENXBIO REPORTS NEW POSITIVE INTERIM DATA FROM PHASE III AFFINITY DUCHENNE TRIAL OF RGX-202 | 03/11/2026 |
| Begin Period Cash Flow | 3 M | |
| Total Cashflows From Investing Activities | 3 M | |
| Free Cash Flow | -2.9 M |
Milestone | Build AI portfolio with Milestone Stock |
Relative Risk vs. Return Landscape
If you had invested $ 35.00 in Milestone Scientific on December 15, 2025 and sold it today you would have lost $ 6.00 from holding Milestone Scientific or given up 17.14% of portfolio value over 90 days. Milestone Scientific does not currently generate positive expected returns and carries 3.7299% risk (volatility on return distribution) over a 90-day horizon. In different words, 33% of stocks are less volatile than Milestone, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Target Price Odds to finish over Current Price
For Milestone Stock, the observed tendency of price to return to a central value is a key input to forecasting models. This mean reversion pattern, however, does not apply uniformly — some stocks remain mispriced for extended periods, suggesting that embedded risk premiums affect the speed of correction.
| Current Price | Horizon | Target Price | Odds moving above the current price in 90 days |
| 0.29 | 90 days | 0.29 | about 50.0 |
According to a normal distribution model, the odds of Milestone Scientific moving above the current price in 90 days from now are about 50.0 (The density curve for Milestone Scientific shows where Milestone Stock price is most likely to settle within 90 days).
Milestone Scientific Price Density |
| Price |
Predictive Modules for Milestone Scientific
A wide range of forecasting techniques can be applied to Milestone Scientific and the broader stock market. While market prediction remains inherently uncertain, combining multiple approaches and evaluating their results is one of the most effective ways to improve the quality of investment decisions.Mean reversion in Milestone Scientific is more reliable over longer time horizons. Short-term deviations can persist and even widen before correcting, making position sizing and risk management critical.
Primary Risk Indicators
The stock market's recent history has been defined by volatility, with multiple large corrections and rallies in the last 10-20 years. Milestone Scientific has participated in these swings. Investors holding Milestone Scientific can protect their portfolios by monitoring Milestone Scientific's risk indicators and implementing appropriate hedging strategies.α | Alpha over Dow Jones | -0.2118 | |
β | Beta against Dow Jones | 0.05 | |
σ | Overall volatility | 0.03 | |
Ir | Information ratio | -0.0418 |
Investor Alerts and Insights
Investors in Milestone Scientific benefit from automated alerts that flag material stock changes as they occur. Milestone Scientific notifications cover technical signals, fundamental shifts, and notable headlines that may impact investment timing.| Milestone Scientific generated a negative expected return over the last 90 days | |
| Milestone Scientific has some characteristics of a very speculative penny stock | |
| Milestone Scientific has high historical volatility and very poor performance | |
| The company reported previous year's revenue of 8.63 M. Net Loss for the year was -4.71 M with profit before overhead, payroll, taxes, and interest of 6.42 M. | |
| Milestone Scientific currently holds about 9.81 M in cash with -2.92 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.14. | |
| Milestone Scientific has a poor financial position based on the latest SEC disclosures | |
| Roughly 23.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: REGENXBIO REPORTS NEW POSITIVE INTERIM DATA FROM PHASE III AFFINITY DUCHENNE TRIAL OF RGX-202 |
Price Density Drivers
Key market indicators for Milestone Scientific reflect the tension between long and short positioning, along with broader investor sentiment. Reviewing the table below helps investors assess the current dynamics driving Milestone Scientific's price behavior.
| Common Stock Shares Outstanding | 79.8 M | |
| Cash And Short Term Investments | 3.3 M |
Milestone Scientific Fundamentals Growth
The market prices Milestone Stock according to Milestone Scientific's ability to generate revenue growth, maintain healthy margins, and manage debt effectively. These fundamental drivers have a direct and measurable impact on Milestone Stock performance.
| Return On Equity | -1.36 | |||
| Return On Asset | -0.42 | |||
| Profit Margin | -0.75 % | |||
| Operating Margin | -0.48 % | |||
| Current Valuation | 22.35 M | |||
| Shares Outstanding | 78.63 M | |||
| Price To Earning | -6.39 X | |||
| Price To Book | 8.88 X | |||
| Price To Sales | 2.54 X | |||
| Revenue | 8.63 M | |||
| Gross Profit | 6.42 M | |||
| EBITDA | -6.72 M | |||
| Net Income | -4.71 M | |||
| Cash And Equivalents | 9.81 M | |||
| Cash Per Share | 0.14 X | |||
| Total Debt | 349.05 K | |||
| Debt To Equity | 0.05 % | |||
| Current Ratio | 3.95 X | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | -2.92 M | |||
| Earnings Per Share | -0.09 X | |||
| Market Capitalization | 22.65 M | |||
| Total Asset | 9.8 M | |||
| Retained Earnings | -128.05 M | |||
| Working Capital | 5.54 M | |||
| Current Asset | 10.74 M | |||
| Current Liabilities | 4.4 M | |||
Performance Metrics & Calculation Methodology
Milestone Scientific performance is measured on a risk-adjusted basis against benchmarks. Liquidity conditions can influence realized performance through spreads and execution cost. Milestone Scientific shows ROE of -136.47%, ROA of -42.34%.
The analytics block for Milestone Scientific relies on periodic company reporting and market reference feeds, with quality checks and normalization applied before rendering. Timing can vary by data vendor. Return and risk statistics are calculated from historical price series.